Skip to main content
SpringerLink
Log in

PET-CT of Esophageal Cancer

  • Chapter
  • First Online:
Clinical PET-CT in Radiology

  • 2080 Accesses

Abstract

There is no established role for the use of 18FDG PET in the screening or initial diagnosis of esophageal carcinoma, although T4 tumors may be diagnosed with PET-CT. In the detection of distant metastatic lymph nodes and other organ metastases FDG PET is more accurate than EUS and CT combined. FDG PET-CT response has been used to guide subsequent treatment. Although the use of 18FDG PET-CT would appear promising as a tool to noninvasively monitor neoadjuvant therapy, further work is required before practical guidelines can be issued on how this should be used in routine practice at the current time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 2004;45:1804–1810.

    PubMed  Google Scholar 

  2. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for Staging of Cancer, 4th ed. Philadelphia: Lippincott, 1992.

    Google Scholar 

  3. Yeung HW, Macapinlac HA, Mazumdar M, Bains M, Finn RD, Larson SM. FDG-PET in esophageal cancer. Incremental value over computed tomography. Clin Positron Imag 1999;2:255–260.

    Article  Google Scholar 

  4. Richter E, Feyerabend T, Bondorf W (eds.). Normal Lymph Node Topography: CT Atlas. Springer: New York, 2004

    Google Scholar 

  5. Benhidjeb T, Hohenberger P. Oesophageal cancer. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C (eds.). Oxford Textbook of Oncology, 2nd ed. Oxford: Oxford University Press, 2002.

    Google Scholar 

  6. Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003;97:1616–1623.

    Article  PubMed  Google Scholar 

  7. Lerut T, Flamen P, Ectors N, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 2000;232:743–752.

    Article  CAS  PubMed  Google Scholar 

  8. Rankin SC, Taylor H, Cook GJ, Mason R. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 1998;53:659–665.

    Article  CAS  PubMed  Google Scholar 

  9. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202–3210.

    CAS  PubMed  Google Scholar 

  10. Bar-Shalom R, Guralnik L, Tsalic M, et al. The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging 2005;32:918–924.

    Google Scholar 

  11. Konski A, Doss M, Milestone B, et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ­ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2005;61:1123–1128.

    Article  PubMed  Google Scholar 

  12. Yoon YC, Lee KS, Shim YM, et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 2003;227:764–770.

    Article  PubMed  Google Scholar 

  13. Ott K, Weber WA, Fink U, et al. Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia. World J Surg 2003;27:1035–1039.

    Article  PubMed  Google Scholar 

  14. Choi JY, Lee KH, Shim YM, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 2000;41:808–815.

    CAS  PubMed  Google Scholar 

  15. Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 1998;78:521–527.

    CAS  PubMed  Google Scholar 

  16. Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR 1997;168:417–424.

    CAS  PubMed  Google Scholar 

  17. Meyers BF, Downey RJ, Decker PA, et al. American College of Surgeons Oncology Group Z0060.The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 2007;133:738–745.

    Article  PubMed  Google Scholar 

  18. Flamen P, Lerut A, Van Cutsem E, et al. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 2000;120:1085–1092.

    Article  CAS  PubMed  Google Scholar 

  19. Weber WA, Ott K, Becker K, et al. Prediction of response to ­preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058–3065.

    CAS  PubMed  Google Scholar 

  20. Wieder HA, Beer AJ, Lordick F, et al. Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction. J Nucl Med 2005;46:2029–2034.

    CAS  PubMed  Google Scholar 

  21. Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 2007;8:797–805.

    Article  PubMed  Google Scholar 

  22. Flamen P, Van Cutsem E, Lerut A, et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002;13:361–368.

    Article  CAS  PubMed  Google Scholar 

  23. Brucher BL, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001;233:300–309.

    Article  CAS  PubMed  Google Scholar 

  24. Levine EA, Farmer MR, Clark P, et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg 2006;243:472–478.

    Article  PubMed  Google Scholar 

  25. Brink I, Hentschel M, Bley TA, et al. Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma. Eur J Surg Oncol 2004;30:544–550.

    Article  CAS  PubMed  Google Scholar 

  26. Nakamura R, Obara T, Katsuragawa S, et al. Failure in presumption of residual disease by quantification of FDG uptake in esophageal squamous cell carcinoma immediately after radiotherapy. Radiat Med 2002;20:181–186.

    PubMed  Google Scholar 

  27. Vrieze O, Haustermans K, De Wever W, et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Radiother Oncol 2004;73:269–275.

    Article  PubMed  Google Scholar 

  28. Leong T, Everitt C, Yuen K, et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 2006;78:254–261.

    Article  PubMed  Google Scholar 

Further Reading

  1. Dehdashti F, Siegel BA. Neoplasms of the esophagus and stomach. Semin Nucl Med 2004;34:198–208.

    Article  PubMed  Google Scholar 

  2. Dobbs J. Practical Radiotherapy Planning. London: Arnold, 1999.

    Google Scholar 

  3. Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004;45:56–68.

    PubMed  Google Scholar 

  4. Rankin S. Oesophageal cancer. In: Husband JES, Reznek RH (eds.). Imaging in Oncology. Oxford: Isis Medical Media Ltd., 1998.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and PET, Royal Marsden Hospital, Downs Rd, Sutton, Surrey, SM2 5PT, UK

    Gary J. R. Cook

Authors
  1. Gary J. R. Cook
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gary J. R. Cook .

Editor information

Editors and Affiliations

  1. Advanced Radiology Services, North Evergreen Drive 3264, Grand Rapids, 49525, Michigan, USA

    Paul Shreve

  2. , Head, PET and SPECT Development, Singapore Bioimaging Consortium, 11 Biopolis Way #02-02 Hel, Singapore, 138667, Singapur, Singapore

    David W. Townsend

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cook, G.J.R. (2011). PET-CT of Esophageal Cancer. In: Shreve, P., Townsend, D. (eds) Clinical PET-CT in Radiology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-48902-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-48902-5_17

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-48900-1

  • Online ISBN: 978-0-387-48902-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation